🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Carmen La Rosa

Merck & Co., Inc., Rahway, NJ, USA (United States)

ORCID: 0000-0002-2072-0924

Also affiliated with National Institutes of Health, National Institute on Drug Abuse, Merck Institute for Science Education

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile
0.315Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Development and implementation of a prescription opioid registry across diverse health systems

JAMIA Open(2022)10.1093/jamiaopen/ooac030
Top 53%
0.315DataRank
Top 53%6 citations

Andrea Altschuler, Ruchir N. Karmali, Ingrid A. Binswanger, Jason M. Glanz, Christina L. Clarke +16 more

Papers

Driven by 9 papers — median percentile 47. Top paper: “The association between buprenorphine treatment duration and mortality: a multi‐site cohort study of people who discontinued treatment”.

The association between buprenorphine treatment duration and mortality: a multi‐site cohort study of people who discontinued treatment

Addiction(2022)10.1111/add.15998
N/A
0.489DataRank · unranked
25 citations

Ingrid A. Binswanger, Christina L. Clarke, Anh P. Nguyen, Morgan A. Ford, G. Thomas Ray +10 more

Development and implementation of a prescription opioid registry across diverse health systems

JAMIA Open(2022)10.1093/jamiaopen/ooac030
Top 53%
0.315DataRank
Top 53%6 citations

Andrea Altschuler, Ruchir N. Karmali, Ingrid A. Binswanger, Jason M. Glanz, Christina L. Clarke +16 more

Implementation of substance use screening in rural federally-qualified health center clinics identified high rates of unhealthy alcohol and cannabis use among adult primary care patients

Addiction Science & Clinical Practice(2023)10.1186/s13722-023-00404-y
N/A
0DataRank · unranked
14 citations

Bethany McLeman, Trip Gardner, Noah Nesin, Vijay Amarendran, Sarah Farkas +9 more

Prescription Opioid Dose Reductions and Potential Adverse Events: a Multi-site Observational Cohort Study in Diverse US Health Systems

Journal of General Internal Medicine(2023)10.1007/s11606-023-08459-y
N/A
0DataRank · unranked
13 citations

G. Thomas Ray, Vanessa A. Palzes, Ingrid A. Binswanger, Andrea Altschuler, Ruchir N. Karmali +15 more

Association of initial opioid prescription duration and an opioid refill by pain diagnosis: Evidence from outpatient settings in ten US health systems

Preventive Medicine(2023)10.1016/j.ypmed.2023.107828
N/A
0DataRank · unranked
0 citations

Vanessa A. Palzes, Ingrid A. Binswanger, Brian K. Ahmedani, Andrea Altschuler, Susan E. Andrade +15 more

Personally-tailored opioid-overdose and medication for opioid use disorder (MOUD) education (TOME) significantly increases MOUD and overdose knowledge in peripartum individuals: Results from a randomized controlled pilot trial

Drug and Alcohol Dependence(2025)10.1016/j.drugalcdep.2025.112795
N/A
0DataRank · unranked
1 citations

Frankie Kropp, Marcela C. Smid, Jessica L Young, Todd H. Davies, Daniel Lewis +7 more

Using digital technologies in clinical trials: Current and future applications

Contemporary Clinical Trials(2020)10.1016/j.cct.2020.106219
N/A
0DataRank · unranked
101 citations

Lisa A. Marsch, Erin L. Winstanley, Meg Brunner, Aimee Campbell, Carmen La Rosa

Impact of a brief personally tailored opioid-overdose and medication for opioid use disorder education intervention on naloxone acceptance in peripartum individuals: A secondary exploratory analysis

Journal of Substance Use and Addiction Treatment(2025)10.1016/j.josat.2025.209816
N/A
0DataRank · unranked
0 citations

Frankie Kropp, Jasmin E. Charles, Gerald Cochran, Antoine Douaihy, Mary Edwards +5 more

Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations

Contemporary Clinical Trials(2020)10.1016/j.cct.2020.106014
N/A
0DataRank · unranked
37 citations

Michelle R. Lofwall, Hendrée E. Jones, Christine M. Wilder, Robert Lindblad, Davida M. Schiff +14 more